Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares FLOT4-AIO: perioperative FLOT versus ECF/ECX for resectable gastric or gastro-oesophageal junction adenocarcinoma, Zolbetuximab, CheckMate 649: nivolumab plus chemotherapy as first treatment for advanced gastric, gastro-oesophageal junction and oesophageal adenocarcinoma, FLOT (5-FU, leucovorin, oxaliplatin, docetaxel) and the tag subtype-page.
Shares PD-L1 CPS (combined positive score), Tislelizumab, Paclitaxel / nab-paclitaxel, Nivolumab and the tag subtype-page.
Shares CAPOX (capecitabine, oxaliplatin), FOLFOX (5-FU, leucovorin, oxaliplatin), Nivolumab, Pembrolizumab and the tag subtype-page.
Shares CAPOX (capecitabine, oxaliplatin), FOLFOX (5-FU, leucovorin, oxaliplatin), Pembrolizumab and the tag subtype-page.
Shares PD-L1 CPS (combined positive score), PD-L1, Paclitaxel / nab-paclitaxel, Pembrolizumab and the tag subtype-page.
Shares Paclitaxel / nab-paclitaxel, Pembrolizumab and the tag subtype-page.
Shares Durvalumab, Paclitaxel / nab-paclitaxel, Pembrolizumab and the tag subtype-page.
Shares Paclitaxel / nab-paclitaxel, Pembrolizumab and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.